RESUMO
Multimodal merging encompasses the ability to localize stimuli based on imprecise information sampled through individual senses such as sight and hearing. Merging decisions are standardly described using Bayesian models that fit behaviors over many trials, encapsulated in a probability distribution. We introduce a novel computational model based on dynamic neural fields able to simulate decision dynamics and generate localization decisions, trial by trial, adapting to varying degrees of discrepancy between audio and visual stimulations. Neural fields are commonly used to model neural processes at a mesoscopic scale-for instance, neurophysiological activity in the superior colliculus. Our model is fit to human psychophysical data of the ventriloquist effect, additionally testing the influence of retinotopic projection onto the superior colliculus and providing a quantitative performance comparison to the Bayesian reference model. While models perform equally on average, a qualitative analysis of free parameters in our model allows insights into the dynamics of the decision and the individual variations in perception caused by noise. We finally show that the increase in the number of free parameters does not result in overfitting and that the parameter space may be either reduced to fit specific criteria or exploited to perform well on more demanding tasks in the future. Indeed, beyond decision or localization tasks, our model opens the door to the simulation of behavioral dynamics, as well as saccade generation driven by multimodal stimulation.
Assuntos
Colículos Superiores , Percepção Visual , Teorema de Bayes , Simulação por Computador , Humanos , Estimulação Luminosa , Probabilidade , Colículos Superiores/fisiologia , Percepção Visual/fisiologiaRESUMO
We report on the development of surface plasmon resonance (SPR) sensors and matching ELISAs for the detection of nucleocapsid and spike antibodies specific against the novel coronavirus 2019 (SARS-CoV-2) in human serum, plasma and dried blood spots (DBS). When exposed to SARS-CoV-2 or a vaccine against SARS-CoV-2, the immune system responds by expressing antibodies at levels that can be detected and monitored to identify the fraction of the population potentially immunized against SARS-CoV-2 and support efforts to deploy a vaccine strategically. A SPR sensor coated with a peptide monolayer and functionalized with various sources of SARS-CoV-2 recombinant proteins expressed in different cell lines detected human anti-SARS-CoV-2 IgG antibodies in clinical samples. Nucleocapsid expressed in different cell lines did not significantly change the sensitivity of the assays, whereas the use of a CHO cell line to express spike ectodomain led to excellent performance. This bioassay was performed on a portable SPR instrument capable of measuring 4 biological samples within 30 minutes of sample/sensor contact and the chip could be regenerated at least 9 times. Multi-site validation was then performed with in-house and commercial ELISA, which revealed excellent cross-correlations with Pearson's coefficients exceeding 0.85 in all cases, for measurements in DBS and plasma. This strategy paves the way to point-of-care and rapid testing for antibodies in the context of viral infection and vaccine efficacy monitoring.
Assuntos
COVID-19 , SARS-CoV-2 , Anticorpos Antivirais , Vacinas contra COVID-19 , Ensaio de Imunoadsorção Enzimática , Humanos , Imunoglobulina G , Sensibilidade e Especificidade , Glicoproteína da Espícula de Coronavírus , Ressonância de Plasmônio de SuperfícieRESUMO
Identification and quantification of proteins in imaging of biological samples are a challenge in today's science. Here, we demonstrate a novel surface plasmon resonance imaging-matrix assisted laser desorption ionization imaging mass spectrometry (SPRi-MALDI IMS) coupled technique competent for the acquisition of multiparametric information by creating a tissue section imprint on an SPRi sensor surface. Correlated images were acquired in SPRi and in MALDI IMS for abundant proteins from a single mouse kidney tissue. The spatial organization of the transferred proteins from the tissue to the SPRi surface was preserved and imaged by SPR and MALDI MS. Surface chemistry was selected to nonspecifically adsorb and retain high concentrations of proteins on the SPRi surface. The diffusion kinetics were controlled to ensure fast transfer of proteins from the tissue sections with minimal lateral diffusion to achieve high spatial fidelity transfer. Lastly, the SPRi instrument was modified to insert a tissue sample in the fluidics chamber to facilitate the real-time measurement of the transfer process. The MALDI IMS experimental conditions, such as matrix deposition and the interface between the SPRi prism and the MALDI IMS instrument, were also optimized. The results show quantitative and regioselective SPRi images correlating to MALDI IMS images of different proteins transferred from a single tissue section.
Assuntos
Proteínas/química , Espectrometria de Massas por Ionização e Dessorção a Laser Assistida por Matriz , Ressonância de Plasmônio de Superfície , Animais , Difusão , Rim/metabolismo , Fígado/metabolismo , CamundongosRESUMO
A simple colorimetric test detects off-flavour profiles of maple syrups in minutes, which are detectable by the naked eye. As flavour profiles are due to complex mixtures of molecules, the test uses nonspecific interactions for analysing the aggregation and color change of Au nanoparticles (AuNPs) induced by the different organic molecules contained in off-flavour maple syrup. The test was optimal with 13 nm citrate-capped AuNPs reacting 1 : 1 with pure maple syrup diluted 10 times. Under these conditions, normal flavour maple syrups did not react and the solution remained red, while off-flavoured maple syrups aggregated the AuNPs and the solution turned blue. Different classes of molecules were then tested to evaluate the types of compounds typically found in maple syrups reacting in the test, showing that sulfur- and amine-containing amino acids and aromatic amines caused aggregation of the AuNPs. The test was validated with 1818 maple syrup samples from the 2018 harvest in Quebec and 98% of the off-flavoured maple syrups were positively identified against the standard taste test. Preliminary tests were performed on site in maple sugar shacks to validate the applicability of the test on the production site.